Primignani Massimo, Tosetti Giulia, Ierardi Anna Maria
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy.
Department of Radiology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan 20122, Italy.
J Transl Int Med. 2023 Sep 2;11(3):198-202. doi: 10.2478/jtim-2023-0113. eCollection 2023 Sep.
Thrombolysis is not currently recommended in cirrhotic patients with acute portal vein thrombosis (PVT) in most guidelines, because of the exceedingly limited data and the perceived high risk of bleeding adverse events. However, in the few studies including patients with cirrhosis, the rate of success was high and that of adverse events was similar in patients with or without cirrhosis. Hence, thrombolysis might be a rescue therapeutic option in patients with cirrhosis and acute, symptomatic thrombosis of the portal venous system, unresponsive to anticoagulation, provided a suitable timing is kept, less than 30 days and, if possible, less than 14 days from the acute onset of portal vein thrombosis. In this review perspective article, I discuss the several potential approaches of thrombolysis, either local or systemic, alone or combined with mechanical procedures for thrombus removal, or as a complement to Transjugular Intrahepatic Portosystemic Shunt placement, with a focus on the more suitable timing of thrombolysis. However, the very limited available data preclude from performing firm recommendations, and decision to carry out thrombolysis must take into account both the occurrence of major contraindications and the current critical clinical setting. In the next future, large high-quality multicentre studies will hopefully be able to settle more firm indications and preferable techniques.
目前,大多数指南不建议对患有急性门静脉血栓形成(PVT)的肝硬化患者进行溶栓治疗,原因是数据极为有限且出血不良事件的风险被认为很高。然而,在少数纳入肝硬化患者的研究中,溶栓成功率很高,且有肝硬化和无肝硬化患者的不良事件发生率相似。因此,对于肝硬化且门静脉系统发生急性、有症状血栓形成且对抗凝治疗无反应的患者,如果能把握合适时机,即门静脉血栓形成急性发作后不到30天,若可能则不到14天,溶栓可能是一种挽救性治疗选择。在这篇综述性观点文章中,我讨论了几种溶栓的潜在方法,包括局部或全身溶栓,单独或与机械性血栓清除程序联合使用,或作为经颈静脉肝内门体分流术(TIPS)置入的补充,重点是更合适的溶栓时机。然而,现有数据非常有限,无法做出确切推荐,进行溶栓的决定必须同时考虑主要禁忌证的出现情况和当前危急的临床状况。在不久的将来,大型高质量多中心研究有望能够确定更确切的适应证和更优的技术。